Suppr超能文献

前哨淋巴结辅助颈部清扫术在晚期口腔鳞状细胞癌中的应用-一种新的分期和治疗方案。

Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.

机构信息

Department of Clinical Sciences Intervention and Technology, Division of ENT Diseases, Karolinska Institute, Stockholm, Sweden.

Medical Unit Head Neck Lung and Skin cancer, Department of Head and Neck Surgery, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Cancer Med. 2023 Jun;12(11):12524-12534. doi: 10.1002/cam4.5966. Epub 2023 Apr 21.

Abstract

BACKGROUND

Sentinel lymph node biopsy (SLNB) is used to improve the staging of and guide treatment in patients with early-stage T1-T2 N0 oral squamous cell carcinoma (OSCC). The role of sentinel nodes (SNs) and the use of SN-technique in advanced OSCC (T3-T4 and/or N+) remain to be evaluated. This study investigates the nodal drainage and the rate of positive SNs (SNs+) in all stages of OSCC.

MATERIALS AND METHODS

In total, 85 patients with T1-T4 OSCC diagnosed 2019-2021 were included. We used a prolonged interval between peritumoral injection of radionuclide and SPECT-CT to include all SNs.

RESULTS

Patients with advanced OSCC presented a higher proportion of contralateral lymphatic drainage and a higher rate of SN+ compared to patients with early-stage disease. T3-T4 and N+ tumors presented a tendency for a higher rate of contralateral lymphatic drainage compared to T1-T2 and N0 tumors (p = 0.1). The prevalence of positive nodes (SNs+) was higher among patients with advanced disease, T3-T4 versus T1-T2 (p = 0.0398).

CONCLUSION

SN-assisted ND enables identification and removal of all SNs + and has the potential for more accurate staging and could possibly give prognostic advantages regarding regional recurrence for all OSCC patients, especially among those with advanced disease. The precise localization of the SNs + also suggests that a more individualized ND approach might be possible in the future even for patients with advanced OSCC.

摘要

背景

前哨淋巴结活检 (SLNB) 用于改善 T1-T2N0 期口腔鳞状细胞癌 (OSCC) 患者的分期并指导治疗。在晚期 OSCC (T3-T4 和/或 N+) 中,前哨淋巴结 (SN) 的作用和 SN 技术的应用仍有待评估。本研究调查了所有 OSCC 分期的淋巴结引流和阳性 SN (SN+) 率。

材料和方法

共纳入 2019 年至 2021 年诊断为 T1-T4 OSCC 的 85 例患者。我们使用放射性核素肿瘤周围注射和 SPECT-CT 之间的延长间隔时间来包括所有 SN。

结果

与早期疾病患者相比,晚期 OSCC 患者表现出更高比例的对侧淋巴引流和更高的 SN+率。与 T1-T2 和 N0 肿瘤相比,T3-T4 和 N+肿瘤的对侧淋巴引流率有更高的趋势(p=0.1)。与早期疾病患者相比,晚期疾病患者中阳性淋巴结 (SNs+) 的患病率更高,T3-T4 与 T1-T2 相比(p=0.0398)。

结论

SN 辅助 ND 能够识别和切除所有 SNs+,具有更准确分期的潜力,并可能为所有 OSCC 患者,特别是晚期疾病患者,提供区域复发的预后优势。SNs+的精确定位还表明,即使对于晚期 OSCC 患者,未来也可能采用更个体化的 ND 方法。

相似文献

本文引用的文献

6
Novel double injection technique for sentinel lymph node biopsy in oral cancer.口腔癌前哨淋巴结活检的新型双注射技术。
Br J Oral Maxillofac Surg. 2021 Dec;59(10):1296-1301. doi: 10.1016/j.bjoms.2021.07.008. Epub 2021 Jul 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验